Business analyst and author Jason Jennings to speak at CRN annual meeting
WASHINGTON — Best-selling author and business leader Jason Jennings will share his five secrets of change at The Conference: CRN’s Annual Symposium for the Dietary Supplement Industry in a keynote address on Nov. 6, the Council for Responsible Nutrition announced Thursday.
Jennings and his research teams have studied the financial performance of more than 220,000 companies worldwide, conducting interviews with more than 11,000 CEOs, business owners and entrepreneurs in the process. He authored the 2012 New York Times bestseller, “The Reinventors—How Great Companies Embrace Constant Radical Change,” and his new book, “The High-Speed Company: Creating Urgency and Growth in a Nanosecond Culture,” will debut in February 2015.
“We know we’re operating in a fast-paced business culture that requires companies to rapidly innovate and embrace new ideas in order to thrive,” stated Steve Mister, president & CEO CRN. “Jennings will deliver motivational and results-based concepts to help reinvigorate your company’s approach to change.”
Walgreens announces quarterly dividend of 33.75 cents per share, representing a 7.1% increase over last year
DEERFIELD, Ill. – The board of directors of Walgreens on Wednesday declared a regular quarterly dividend of 33.75 cents per share, a 7.1% increase over the year ago dividend.
The dividend is payable Dec. 12, 2014, to shareholders of record as of Nov. 17, 2014.
Walgreens has paid a dividend in 328 straight quarters (82 years) and has raised its dividend for 39 consecutive years. Over the last five years, Walgreens annual dividend rate has increased from 55 cents per share to $1.35 per share, resulting in a compound annual growth rate of nearly 20%.
Congress, industry call on FDA to ban DMBA from sports nutrition supplements
WASHINGTON — Congress and the sports nutrition industry independently called upon the Food and Drug Administration on Wednesday to act on removing an untested synthetic stimulant that was found in 12 products marketed as sports nutrition supplements, according to research published online yesterday by the journal Drug Testing and Analysis.
"A synthetic stimulant never before studied in humans, 1,3-dimethylbutylamine (DMBA), was suspected of being present in dietary supplements," noted lead researcher Pieter Cohen, of Harvard Medical School. "DMBA is an analogue of the pharmaceutical stimulant, 1,3-dimethylamylamine (DMAA), which was recently banned by the U.S. Food and Drug Administration," he wrote. "The stimulant has never been studied in humans; its efficacy and safety are entirely unknown. Regulatory agencies should act expeditiously to warn consumers and remove DMBA from all dietary supplements."
“We agree with the authors of this analysis that DMBA is an illegal dietary ingredient and therefore should not be used in dietary supplements," stated Steve Mister, president and CEO for the Council for Responsible Nutrition. "In fact, last month, CRN formally requested that the Food and Drug Administration investigate the regulatory status of this ingredient, marketed as Amp or Amp Citrate," he said. "Further, we urged the agency to consider the potential dangers of this product, given it is a similar substance, in chemical structure and in effect, to DMAA, an ingredient already prohibited by FDA from use in dietary supplements."
Sens. Richard Durbin, D-Ill., and Richard Blumenthal, D-Conn., also called the agency to task in banning this ingredient. "We call on FDA to take action against products containing DMBA," the senators wrote. "We believe products containing DMBA are adulterated and/or misbranded, and the FDA has a responsibility … to take action against the manufacturers of such products."
According to a USA Today report published Thursday morning, GNC has stopped selling supplements containing DMBA as of Wednesday.
Loading Post Please Wait...